Division of Cardiovascular Surgery, NorthShore University HealthSystem, Evanston, Illinois.
Department of Cardiovascular Medicine, Mayo Clinic Hospital, Rochester, Minnesota.
J Am Coll Cardiol. 2018 Sep 25;72(13):1437-1448. doi: 10.1016/j.jacc.2018.07.033.
Mitral valve replacement in the setting of severe mitral annular calcification remains a surgical challenge. Transcatheter mitral valve replacement (TMVR) using an aortic balloon-expandable transcatheter heart valve is emerging as a potential treatment option for high surgical risk patients. Transseptal, transapical, or transatrial access is not always feasible, so an understanding of alternative implantation techniques is important.
The authors sought to present a step-by-step description of a contemporary transatrial TMVR technique using balloon-expandable aortic transcatheter heart valves. This procedure has evolved over time to address valve migration, left ventricular outflow tract obstruction, and paravalvular leak. The authors present a refined technique that has been associated with the most reproducible outcomes.
A step-by-step description of the TMVR technique and outcomes of 8 patients treated using this technique are described. Baseline patient clinical and echocardiographic characteristics and 30-day post-TMVR outcomes are presented.
Eight patients underwent transatrial TMVR at a single institution. Five had previous cardiac surgery. Mean STS score was 8%. Technical success by MVARC (Mitral Valve Academic Research Consortium) criteria was 100%. There was zero in-hospital and 30-day mortality. Procedural success by MVARC criteria at 30 days was 100%. Paravalvular leak immediately post-implant was none or trace in 6 and mild in 1.
The technique described is reproducible and was associated with favorable outcomes in this early experience. It represents a useful technique for the treatment of mitral valve disease in the setting of severe annular calcification. A structured and defined implantation technique is critical to investigators as this field evolves.
在严重二尖瓣环钙化的情况下进行二尖瓣置换仍然是一项手术挑战。使用主动脉球囊扩张经导管心脏瓣膜的经导管二尖瓣置换术(TMVR)作为高手术风险患者的潜在治疗选择正在出现。经房间隔、经心尖或经心房入路并不总是可行的,因此了解替代植入技术很重要。
作者旨在介绍一种使用主动脉球囊扩张经导管心脏瓣膜的经心房 TMVR 技术的分步描述。该程序随着时间的推移不断发展,以解决瓣膜迁移、左心室流出道梗阻和瓣周漏问题。作者提出了一种经过改进的技术,该技术与最可重复的结果相关。
描述了 8 例使用该技术治疗的 TMVR 技术的分步说明和结果。介绍了基线患者的临床和超声心动图特征以及 30 天 TMVR 后的结果。
8 例患者在一家机构接受了经心房 TMVR。5 例患者曾接受过心脏手术。STS 评分平均为 8%。根据 MVARC(二尖瓣学术研究联盟)标准,技术成功率为 100%。无院内和 30 天死亡率。根据 MVARC 标准,30 天的手术成功率为 100%。植入后即刻瓣周漏为无或微量 6 例,轻度 1 例。
在早期经验中,所描述的技术是可重复的,并取得了良好的结果。对于严重环形钙化的二尖瓣疾病的治疗,它代表了一种有用的技术。随着该领域的发展,一种结构化和明确的植入技术对研究人员来说至关重要。